- Home
- SPPL vs CDIO Comparison
SPPL vs CDIO Comparison
Compare SPPL & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPL
- CDIO
- Stock Information
- Founded
- SPPL 2016
- CDIO 2017
- Country
- SPPL Singapore
- CDIO United States
- Employees
- SPPL N/A
- CDIO N/A
- Industry
- SPPL
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SPPL
- CDIO Health Care
- Exchange
- SPPL Nasdaq
- CDIO Nasdaq
- Market Cap
- SPPL 9.8M
- CDIO 8.0M
- IPO Year
- SPPL 2023
- CDIO N/A
- Fundamental
- Price
- SPPL $6.00
- CDIO $4.48
- Analyst Decision
- SPPL
- CDIO
- Analyst Count
- SPPL 0
- CDIO 0
- Target Price
- SPPL N/A
- CDIO N/A
- AVG Volume (30 Days)
- SPPL 14.0K
- CDIO 47.5K
- Earning Date
- SPPL 01-01-0001
- CDIO 11-12-2025
- Dividend Yield
- SPPL N/A
- CDIO N/A
- EPS Growth
- SPPL N/A
- CDIO N/A
- EPS
- SPPL N/A
- CDIO N/A
- Revenue
- SPPL $4,591,508.00
- CDIO $19,507.00
- Revenue This Year
- SPPL N/A
- CDIO $1,434.82
- Revenue Next Year
- SPPL N/A
- CDIO $4,661.91
- P/E Ratio
- SPPL N/A
- CDIO N/A
- Revenue Growth
- SPPL 24.27
- CDIO N/A
- 52 Week Low
- SPPL $2.16
- CDIO $3.22
- 52 Week High
- SPPL $16.80
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- SPPL 58.28
- CDIO 53.11
- Support Level
- SPPL $5.33
- CDIO $4.03
- Resistance Level
- SPPL $7.00
- CDIO $4.66
- Average True Range (ATR)
- SPPL 0.41
- CDIO 0.35
- MACD
- SPPL -0.06
- CDIO -0.02
- Stochastic Oscillator
- SPPL 43.69
- CDIO 47.57
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.